Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention : rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1573105974098302592
  • NII論文ID
    20001500596
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ